Authors: Yanlin Wang; Shi Tang; Lianqing Zhang; Xuan Bu; Lu Lu; Hailong Li; Yingxue Gao; Xinyu Hu; Weihong Kuang; Zhiyun Jia; John A. Sweeney; Qiyong Gong; Xiaoqi Huang · Research
Can Brain Scans and Symptoms Reveal Different Types of Depression?
A study identified two subtypes of major depression with distinct brain connectivity patterns and symptom profiles, suggesting potential for personalized treatments.
Source: Wang, Y., Tang, S., Zhang, L., Bu, X., Lu, L., Li, H., Gao, Y., Hu, X., Kuang, W., Jia, Z., Sweeney, J. A., Gong, Q., & Huang, X. (2021). Data-driven clustering differentiates subtypes of major depressive disorder with distinct brain connectivity and symptom features. The British Journal of Psychiatry, 219(4), 606-613. https://doi.org/10.1192/bjp.2021.103
What you need to know
- The study identified two subtypes of depression with different brain connectivity patterns and symptom profiles
- One subtype had more insomnia and overactive attention networks, while the other had more anhedonia and underactive reward/motivation networks
- Identifying distinct depression subtypes could lead to more personalized and effective treatments
Background
Major depressive disorder (MDD) is a complex mental health condition that can vary significantly between individuals in terms of symptoms, causes, and treatment response. This diversity makes it challenging for doctors to provide targeted, effective treatments. Recent research has aimed to identify distinct subtypes of depression to help address this issue.
This study used advanced brain imaging and data analysis techniques to see if there are identifiable subtypes of depression with unique brain activity patterns and symptoms. The goal was to gain insights that could potentially lead to more personalized depression treatments.
How the study worked
The researchers recruited 115 people diagnosed with MDD who had never taken antidepressant medications before. They also included 129 healthy individuals without depression for comparison.
All participants underwent brain scans using functional magnetic resonance imaging (fMRI) to measure activity and connectivity between different brain regions. The people with depression also completed detailed questionnaires about their symptoms.
Using sophisticated statistical techniques, the researchers analyzed the brain scans and symptom data together to see if there were distinct patterns or subtypes of depression.
Two depression subtypes identified
The analysis revealed two main subtypes of depression with different brain connectivity patterns and symptom profiles:
Subtype 1: Insomnia-dominated
This group showed:
- More problems with sleep, especially difficulty staying asleep
- Increased connectivity in brain networks involved in attention and detecting important information (called the ventral attention network)
Subtype 2: Anhedonia-dominated
This group exhibited:
- More anhedonia (difficulty feeling pleasure) and feelings of guilt
- Decreased connectivity in brain circuits involved in reward and motivation (subcortical networks) and focusing attention (dorsal attention network)
Importantly, the overall severity of depression was similar between the two subtypes. The differences were in the specific symptoms and brain activity patterns.
Shared brain changes
While there were distinct differences between the subtypes, the researchers also found some brain connectivity changes that were common across both groups compared to people without depression. These included:
- Decreased connectivity in networks involved in processing sensory information and emotions
- Increased connectivity between networks involved in self-reflection and emotional regulation
This suggests there may be some core brain changes in depression, along with subtype-specific differences.
Why this matters
Identifying distinct biological subtypes of depression is an important step toward developing more personalized and effective treatments. The findings suggest that different approaches may be beneficial for different subtypes of depression. For example:
- For subtype 1 (insomnia-dominated), treatments targeting sleep and overactive attention networks may be most helpful
- For subtype 2 (anhedonia-dominated), approaches focused on increasing reward sensitivity and motivation may be more beneficial
Additionally, understanding the shared brain changes across depression subtypes could help identify core processes to target with treatments that may benefit most people with depression.
Limitations and next steps
This study provides valuable insights, but more research is needed to confirm and expand on the findings. Some limitations to consider:
- The study only included people who had never taken antidepressants. The subtypes may look different in those with longstanding depression or medication exposure.
- Brain scans were only done at one point in time. Following people over time could reveal how stable these subtypes are.
- The study was done in one country (China). Research in other populations is needed to see if the subtypes are consistent across cultures.
Future studies should aim to:
- Replicate these findings in larger, diverse groups of people with depression
- Test if matching treatments to depression subtypes leads to better outcomes
- Investigate if there are other important subtypes beyond the two identified here
- Examine how genetics and life experiences may contribute to different depression subtypes
Conclusions
- Advanced brain imaging and data analysis revealed two subtypes of depression with distinct symptoms and brain connectivity patterns
- One subtype had more insomnia and overactive attention networks, while the other had more anhedonia and underactive reward networks
- Identifying depression subtypes could lead to more personalized and effective treatments, though more research is needed
This study represents an important step toward unraveling the complexity of depression and developing targeted treatments. While we’re not yet at the point of using brain scans to guide depression treatment in regular clinical practice, this line of research holds promise for improving care for people with depression in the future.